ZED-1227 is a novel, potent, selective and orally bioactive tissue transglutaminase (TGM2) inhibitor (IC50 of 45 nM) with the potential to be used for the treatment of celiac disease. It can block inflammation-induced TG2 expression and activity.

纯度：≥98%

CAS：1542132-88-6